skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Results 1 - 20 of 28,904  for All Library Resources

Sorted by: Sorted by: RelevanceOr hit Enter to replace sort method
Results 1 2 3 4 5 next page
Show only
Refined by: subject: Studies remove
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Revised STandards for Reporting Interventions in Clinical Trials of Acupuncture (STRICTA): extending the CONSORT statement
Revised STandards for Reporting Interventions in Clinical Trials of Acupuncture (STRICTA): extending the CONSORT statement
Material Type:
Article 		Add to My Research

Revised STandards for Reporting Interventions in Clinical Trials of Acupuncture (STRICTA): extending the CONSORT statement

PLoS medicine, 2010-06, Vol.7 (6), p.e1000261-e1000261 [Peer Reviewed Journal]

MacPherson et al. 2010 ;2010 MacPherson et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited: MacPherson H, Altman DG, Hammerschlag R, Youping L, Taixiang W, et al. (2010) Revised STandards for Reporting Interventions in Clinical Trials of Acupuncture (STRICTA): Extending the CONSORT Statement. PLoS Med 7(6): e1000261. doi:10.1371/journal.pmed.1000261 ;ISSN: 1549-1676 ;ISSN: 1549-1277 ;EISSN: 1549-1676 ;DOI: 10.1371/journal.pmed.1000261 ;PMID: 20543992

Full text available

Citations Cited by
2
Entrectinib in ROS1 fusion-positive non-small-cell lung cancer: integrated analysis of three phase 1–2 trials
Entrectinib in ROS1 fusion-positive non-small-cell lung cancer: integrated analysis of three phase 1–2 trials
Material Type:
Article 		Add to My Research

Entrectinib in ROS1 fusion-positive non-small-cell lung cancer: integrated analysis of three phase 1–2 trials

The lancet oncology, 2020-02, Vol.21 (2), p.261-270 [Peer Reviewed Journal]

2020 Elsevier Ltd ;Copyright © 2020 Elsevier Ltd. All rights reserved. ;2020. Elsevier Ltd ;Distributed under a Creative Commons Attribution 4.0 International License ;ISSN: 1470-2045 ;EISSN: 1474-5488 ;DOI: 10.1016/S1470-2045(19)30690-4 ;PMID: 31838015

Full text available

Citations Cited by
3
SPIRIT 2013: new guidance for content of clinical trial protocols
SPIRIT 2013: new guidance for content of clinical trial protocols
Material Type:
Article 		Add to My Research

SPIRIT 2013: new guidance for content of clinical trial protocols

The Lancet (British edition), 2013-01, Vol.381 (9861), p.91-92 [Peer Reviewed Journal]

Elsevier Ltd ;2013 Elsevier Ltd ;Copyright Elsevier Limited Jan 12, 2013 ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(12)62160-6 ;PMID: 23305999 ;CODEN: LANCAO

Full text available

Citations Cited by
4
Many-to-one comparisons after safety selection in multi-arm clinical trials
Many-to-one comparisons after safety selection in multi-arm clinical trials
Material Type:
Article 		Add to My Research

Many-to-one comparisons after safety selection in multi-arm clinical trials

PloS one, 2017-06, Vol.12 (6), p.e0180131-e0180131 [Peer Reviewed Journal]

COPYRIGHT 2017 Public Library of Science ;COPYRIGHT 2017 Public Library of Science ;2017 Hlavin et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2017 Hlavin et al 2017 Hlavin et al ;ISSN: 1932-6203 ;EISSN: 1932-6203 ;DOI: 10.1371/journal.pone.0180131 ;PMID: 28651023

Full text available

Citations Cited by
5
Developing Core Outcome Measurement Sets for Clinical Trials: OMERACT Filter 2.0
Developing Core Outcome Measurement Sets for Clinical Trials: OMERACT Filter 2.0
Material Type:
Article 		Add to My Research

Developing Core Outcome Measurement Sets for Clinical Trials: OMERACT Filter 2.0

Journal of clinical epidemiology, 2014-07, Vol.67 (7), p.745-753 [Peer Reviewed Journal]

The Authors ;2014 The Authors ;2015 INIST-CNRS ;Copyright © 2014 The Authors. Published by Elsevier Inc. All rights reserved. ;Copyright Elsevier Limited Jul 2014 ;ISSN: 0895-4356 ;EISSN: 1878-5921 ;DOI: 10.1016/j.jclinepi.2013.11.013 ;PMID: 24582946

Full text available

Citations Cited by
6
The Hartung-Knapp-Sidik-Jonkman method for random effects meta-analysis is straightforward and considerably outperforms the standard DerSimonian-Laird method
The Hartung-Knapp-Sidik-Jonkman method for random effects meta-analysis is straightforward and considerably outperforms the standard DerSimonian-Laird method
Material Type:
Article 		Add to My Research

The Hartung-Knapp-Sidik-Jonkman method for random effects meta-analysis is straightforward and considerably outperforms the standard DerSimonian-Laird method

BMC medical research methodology, 2014-02, Vol.14 (1), p.25-25, Article 25 [Peer Reviewed Journal]

2014 IntHout et al.; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. ;Copyright © 2014 IntHout et al.; licensee BioMed Central Ltd. 2014 IntHout et al.; licensee BioMed Central Ltd. ;ISSN: 1471-2288 ;EISSN: 1471-2288 ;DOI: 10.1186/1471-2288-14-25 ;PMID: 24548571

Full text available

Citations Cited by
7
Adaptive platform trials: definition, design, conduct and reporting considerations
Adaptive platform trials: definition, design, conduct and reporting considerations
Material Type:
Article 		Add to My Research

Adaptive platform trials: definition, design, conduct and reporting considerations

Nature reviews. Drug discovery, 2019-10, Vol.18 (10), p.797-807 [Peer Reviewed Journal]

COPYRIGHT 2019 Nature Publishing Group ;Copyright Nature Publishing Group Oct 2019 ;ISSN: 1474-1776 ;EISSN: 1474-1784 ;DOI: 10.1038/s41573-019-0034-3 ;PMID: 31462747

Full text available

Citations Cited by
8
Examining and Enabling the Role of Health Care Providers as Patient Engagement Facilitators in Clinical Trials
Examining and Enabling the Role of Health Care Providers as Patient Engagement Facilitators in Clinical Trials
Material Type:
Article 		Add to My Research

Examining and Enabling the Role of Health Care Providers as Patient Engagement Facilitators in Clinical Trials

Clinical therapeutics, 2017-11, Vol.39 (11), p.2203-2213 [Peer Reviewed Journal]

2017 Elsevier HS Journals, Inc. ;Copyright © 2017 Elsevier HS Journals, Inc. All rights reserved. ;Copyright Elsevier Limited Nov 2017 ;ISSN: 0149-2918 ;EISSN: 1879-114X ;DOI: 10.1016/j.clinthera.2017.09.014 ;PMID: 29079388

Full text available

Citations Cited by
9
American College of Rheumatology/European League Against Rheumatism Provisional Definition of Remission in Rheumatoid Arthritis for Clinical Trials
American College of Rheumatology/European League Against Rheumatism Provisional Definition of Remission in Rheumatoid Arthritis for Clinical Trials
Material Type:
Article 		Add to My Research

American College of Rheumatology/European League Against Rheumatism Provisional Definition of Remission in Rheumatoid Arthritis for Clinical Trials

Annals of the Rheumatic Diseases, 2011-03, Vol.70 (3), p.404-413 [Peer Reviewed Journal]

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions ;2015 INIST-CNRS ;Copyright: 2011 Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions ;ISSN: 0003-4967 ;EISSN: 1468-2060 ;DOI: 10.1136/ard.2011.149765 ;PMID: 21292833 ;CODEN: ARDIAO

Full text available

Citations Cited by
10
Investigating clinical heterogeneity in systematic reviews: a methodologic review of guidance in the literature
Investigating clinical heterogeneity in systematic reviews: a methodologic review of guidance in the literature
Material Type:
Article 		Add to My Research

Investigating clinical heterogeneity in systematic reviews: a methodologic review of guidance in the literature

BMC medical research methodology, 2012-07, Vol.12 (1), p.111-111, Article 111 [Peer Reviewed Journal]

COPYRIGHT 2012 BioMed Central Ltd. ;2012 Gagnier et al.; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. ;Copyright ©2012 Gagnier et al.; licensee BioMed Central Ltd. 2012 Gagnier et al.; licensee BioMed Central Ltd. ;ISSN: 1471-2288 ;EISSN: 1471-2288 ;DOI: 10.1186/1471-2288-12-111 ;PMID: 22846171

Full text available

Citations Cited by
11
Using the Delphi technique to determine which outcomes to measure in clinical trials: recommendations for the future based on a systematic review of existing studies
Using the Delphi technique to determine which outcomes to measure in clinical trials: recommendations for the future based on a systematic review of existing studies
Material Type:
Article 		Add to My Research

Using the Delphi technique to determine which outcomes to measure in clinical trials: recommendations for the future based on a systematic review of existing studies

PLoS medicine, 2011-01, Vol.8 (1), p.e1000393-e1000393 [Peer Reviewed Journal]

COPYRIGHT 2011 Public Library of Science ;COPYRIGHT 2011 Public Library of Science ;2011 Sinha et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited: Sinha IP, Smyth RL, Williamson PR (2011) Using the Delphi Technique to Determine Which Outcomes to Measure in Clinical Trials: Recommendations for the Future Based on a Systematic Review of Existing Studies. PLoS Med 8(1): e1000393. doi:10.1371/journal.pmed.1000393 ;Sinha et al. 2011 ;ISSN: 1549-1676 ;ISSN: 1549-1277 ;EISSN: 1549-1676 ;DOI: 10.1371/journal.pmed.1000393 ;PMID: 21283604

Full text available

Citations Cited by
12
A minimal common outcome measure set for COVID-19 clinical research
A minimal common outcome measure set for COVID-19 clinical research
Material Type:
Article 		Add to My Research

A minimal common outcome measure set for COVID-19 clinical research

The Lancet infectious diseases, 2020-08, Vol.20 (8), p.e192-e197 [Peer Reviewed Journal]

2020 Elsevier Ltd ;Copyright © 2020 Elsevier Ltd. All rights reserved. ;2020. Elsevier Ltd ;2020 Elsevier Ltd. All rights reserved. 2020 Elsevier Ltd ;ISSN: 1473-3099 ;EISSN: 1474-4457 ;DOI: 10.1016/S1473-3099(20)30483-7 ;PMID: 32539990

Full text available

Citations Cited by
13
Safety and Tolerability of Empagliflozin in Patients with Type 2 Diabetes
Safety and Tolerability of Empagliflozin in Patients with Type 2 Diabetes
Material Type:
Article 		Add to My Research

Safety and Tolerability of Empagliflozin in Patients with Type 2 Diabetes

Clinical therapeutics, 2016-06, Vol.38 (6), p.1299-1313 [Peer Reviewed Journal]

The Authors ;2016 The Authors ;Copyright © 2016 The Authors. Published by Elsevier Inc. All rights reserved. ;Copyright Elsevier Limited Jun 01, 2016 ;ISSN: 0149-2918 ;EISSN: 1879-114X ;DOI: 10.1016/j.clinthera.2016.03.031 ;PMID: 27085585

Full text available

Citations Cited by
14
Consensus on Exercise Reporting Template (CERT): Modified Delphi Study
Consensus on Exercise Reporting Template (CERT): Modified Delphi Study
Material Type:
Article 		Add to My Research

Consensus on Exercise Reporting Template (CERT): Modified Delphi Study

Physical therapy, 2016-10, Vol.96 (10), p.1514-1524 [Peer Reviewed Journal]

2016 American Physical Therapy Association 2016 ;2016 American Physical Therapy Association. ;COPYRIGHT 2016 Oxford University Press ;COPYRIGHT 2016 Oxford University Press ;Copyright AMERICAN PHYSICAL THERAPY ASSOCIATION Oct 2016 ;ISSN: 0031-9023 ;EISSN: 1538-6724 ;DOI: 10.2522/ptj.20150668 ;PMID: 27149962

Full text available

Citations Cited by
15
GRADE guidelines: 18. How ROBINS-I and other tools to assess risk of bias in nonrandomized studies should be used to rate the certainty of a body of evidence
GRADE guidelines: 18. How ROBINS-I and other tools to assess risk of bias in nonrandomized studies should be used to rate the certainty of a body of evidence
Material Type:
Article 		Add to My Research

GRADE guidelines: 18. How ROBINS-I and other tools to assess risk of bias in nonrandomized studies should be used to rate the certainty of a body of evidence

Journal of clinical epidemiology, 2019-07, Vol.111, p.105-114 [Peer Reviewed Journal]

2018 Elsevier Inc. ;Copyright © 2018 Elsevier Inc. All rights reserved. ;2018. Elsevier Inc. ;ISSN: 0895-4356 ;EISSN: 1878-5921 ;DOI: 10.1016/j.jclinepi.2018.01.012 ;PMID: 29432858

Full text available

Citations Cited by
16
Recruitment failure and futility were the most common reasons for discontinuation of clinical drug trials. Results of a nationwide inception cohort study in the Netherlands
Recruitment failure and futility were the most common reasons for discontinuation of clinical drug trials. Results of a nationwide inception cohort study in the Netherlands
Material Type:
Article 		Add to My Research

Recruitment failure and futility were the most common reasons for discontinuation of clinical drug trials. Results of a nationwide inception cohort study in the Netherlands

Journal of clinical epidemiology, 2017-08, Vol.88, p.140-147 [Peer Reviewed Journal]

Elsevier Inc. ;2017 Elsevier Inc. ;Copyright © 2017 Elsevier Inc. All rights reserved. ;Copyright Elsevier Science Ltd. Aug 1, 2017 ;ISSN: 0895-4356 ;EISSN: 1878-5921 ;DOI: 10.1016/j.jclinepi.2017.05.001 ;PMID: 28487159

Full text available

Citations Cited by
17
Genomically annotated risk model for advanced renal-cell carcinoma: a retrospective cohort study
Genomically annotated risk model for advanced renal-cell carcinoma: a retrospective cohort study
Material Type:
Article 		Add to My Research

Genomically annotated risk model for advanced renal-cell carcinoma: a retrospective cohort study

The lancet oncology, 2018-12, Vol.19 (12), p.1688-1698 [Peer Reviewed Journal]

2018 Elsevier Ltd ;Copyright © 2018 Elsevier Ltd. All rights reserved. ;Copyright Elsevier Limited Dec 2018 ;ISSN: 1470-2045 ;EISSN: 1474-5488 ;DOI: 10.1016/S1470-2045(18)30648-X ;PMID: 30416077

Full text available

Citations Cited by
18
Independent data monitoring committees: Preparing a path for the future
Independent data monitoring committees: Preparing a path for the future
Material Type:
Article 		Add to My Research

Independent data monitoring committees: Preparing a path for the future

The American heart journal, 2014-08, Vol.168 (2), p.135-141.e1 [Peer Reviewed Journal]

Mosby, Inc. ;2014 Mosby, Inc. ;Copyright © 2014 Mosby, Inc. All rights reserved. ;Copyright Elsevier Limited Aug 2014 ;2014, Mosby, Inc. All rights reserved. 2014 ;ISSN: 0002-8703 ;EISSN: 1097-6744 ;DOI: 10.1016/j.ahj.2014.05.003 ;PMID: 25066551 ;CODEN: AHJOA2

Full text available

Citations Cited by
19
Industry funding was associated with increased use of core outcome sets
Industry funding was associated with increased use of core outcome sets
Material Type:
Article 		Add to My Research

Industry funding was associated with increased use of core outcome sets

Journal of clinical epidemiology, 2019-11, Vol.115, p.90-97 [Peer Reviewed Journal]

Elsevier Inc. ;2019 Elsevier Inc. ;Copyright © 2019 Elsevier Inc. All rights reserved. ;2019. Elsevier Inc. ;ISSN: 0895-4356 ;EISSN: 1878-5921 ;DOI: 10.1016/j.jclinepi.2019.07.007 ;PMID: 31326541

Full text available

Citations Cited by
20
Does Publication Bias Inflate the Apparent Efficacy of Psychological Treatment for Major Depressive Disorder? A Systematic Review and Meta-Analysis of US National Institutes of Health-Funded Trials
Does Publication Bias Inflate the Apparent Efficacy of Psychological Treatment for Major Depressive Disorder? A Systematic Review and Meta-Analysis of US National Institutes of Health-Funded Trials
Material Type:
Article 		Add to My Research

Does Publication Bias Inflate the Apparent Efficacy of Psychological Treatment for Major Depressive Disorder? A Systematic Review and Meta-Analysis of US National Institutes of Health-Funded Trials

PloS one, 2015-09, Vol.10 (9), p.e0137864-e0137864 [Peer Reviewed Journal]

COPYRIGHT 2015 Public Library of Science ;COPYRIGHT 2015 Public Library of Science ;2015 Driessen et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2015 Driessen et al 2015 Driessen et al ;ISSN: 1932-6203 ;EISSN: 1932-6203 ;DOI: 10.1371/journal.pone.0137864 ;PMID: 26422604

Full text available

Citations Cited by

Results 1 - 20 of 28,904  for All Library Resources

Sorted by: Sorted by: RelevanceOr hit Enter to replace sort method
Results 1 2 3 4 5 next page

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Show only

  1. Peer-reviewed Journals (26,379)

Refine My Results

Creation Date 

From To
Refine
  1. Before 1992  (20)
  2. 1992 To 1999  (291)
  3. 2000 To 2007  (2,440)
  4. 2008 To 2016  (14,807)
  5. After 2016  (11,347)
  6. More options open sub menu

Subject 

  1. Clinical Trials  (27,211)
  2. Science & Technology  (23,385)
  3. Life Sciences & Biomedicine  (19,222)
  4. Humans  (17,499)
  5. Female  (8,515)
  6. Patients  (8,032)
  7. Male  (7,757)
  8. Medical Research  (5,857)
  9. Middle Aged  (5,478)
  10. Adult  (5,075)
  11. Medicine  (4,276)
  12. Aged  (4,124)
  13. Treatment Outcome  (4,104)
  14. Care And Treatment  (4,021)
  15. Systematic Review  (3,959)
  16. Science & Technology - Other Topics  (3,915)
  17. Multidisciplinary Sciences  (3,896)
  18. Mortality  (3,786)
  19. Analysis  (3,751)
  20. More options open sub menu

Language 

  1. English  (28,894)
  2. Japanese  (3,349)
  3. Portuguese  (32)
  4. French  (30)
  5. Norwegian  (19)
  6. German  (12)
  7. Spanish  (11)
  8. Turkish  (9)
  9. Russian  (5)
  10. Italian  (5)
  11. Chinese  (5)
  12. Polish  (4)
  13. Swedish  (1)
  14. Catalan  (1)
  15. Bulgarian  (1)
  16. More options open sub menu
INSPIRE LIBRARY - TON DUC THANG UNIVERSITY (84-028) 37 755 057 Feedback
19 Nguyen Huu Tho St. Dist.7, HCM thuvien@tdtu.edu.vn

Copyright © 2017 INSPIRE LIBRARY - TON DUC THANG UNIVERSITY

Searching Remote Databases, Please Wait